AVL, the only independent fish vaccine company in the world, is seeking to raise some £5m (€8.12m) of new money to expand its business overseas, particularly in South East Asia.

AVL has appointed Old Mutual Securities to find new funds after ruling out an Alternative Investment Market flotation. It would also be interested in a strategic partner, such as a pharmaceuticals company, because of potential synergies.